Search

everythinglearnresearchcommunity

for

Search:↓

Sustained-release sodium valproate is effective in treating epilepsy, with some side effects influenced by genetics.

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Combining glycyrrhizin and UVB light is most effective for improving vitiligo.

Hinokiflavone may help treat cancers and other health issues.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

Long-read RNA sequencing can identify complex gene changes in IFAP syndrome.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Levamisole and finasteride can reduce DHT production, potentially preventing phenytoin-induced gum overgrowth.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Improving medical training is key to eradicating frambusia by 2030.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

NB-002 is a promising new topical treatment for fungal nail infections, showing better results than a non-medicated option.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Inducing ferroptosis in hepatic stellate cells is crucial for treating liver fibrosis.

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Simvastatin reduces inflammation and promotes hair regrowth in alopecia areata.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

The new drug carriers show promise for better targeting and treating ovarian cancer.